⌘K

Login Start Free

Home/Filings/4/0001213900-23-020675

4//SEC Filing

MURPHY JOHN RAYMOND 4

Accession 0001213900-23-020675

CIK 0001937993other

View on SEC.gov Company Profile

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 5:27 PM ET

Size

4.4 KB

Accession

0001213900-23-020675

Insider Transaction Report

Form 4

Period: 2023-03-16

Cadrenal Therapeutics, Inc.CVKD

MURPHY JOHN RAYMOND

Director

Transactions

Purchase
Common Stock
2023-03-16$1.67/sh+20,000$33,398→ 574,792 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Cadrenal Therapeutics, Inc.

CIK 0001937993

Entity typeother

Related Parties

1

filerCIK 0001275195

Filing Metadata

Form type: 4
Filed: Mar 15, 8:00 PM ET
Accepted: Mar 16, 5:27 PM ET
Size: 4.4 KB

View on SEC.gov